Literature DB >> 25932584

Chikungunya, the emerging migratory rheumatism.

Patricio Alfaro-Toloza1, Diego E Clouet-Huerta2, Alfonso J Rodríguez-Morales3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25932584     DOI： 10.1016/S1473-3099(15)70160-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  19 in total

1.  Post-chikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia.

Authors:  Alfonso J Rodriguez-Morales; Wilmer Villamil-Gomez; Mara Merlano-Espinosa; Laure Simone-Kleber
Journal:  Clin Rheumatol       Date:  2015-08-05       Impact factor: 2.980

2.  How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America?

Authors:  A J Rodriguez-Morales; J A Cardona-Ospina; W Villamil-Gómez; A E Paniz-Mondolfi
Journal:  Rheumatol Int       Date:  2015-06-05       Impact factor: 2.631

3.  Chikungunya or not, differential diagnosis and the importance of laboratory confirmation for clinical and epidemiological research: comment on the article by Rosario et al.

Authors:  Jaime Andrés Cardona-Ospina; Felipe Vera-Polania; Alfonso J Rodriguez-Morales
Journal:  Clin Rheumatol       Date:  2015-06-19       Impact factor: 2.980

4.  Would be IL-6 a missing link between chronic inflammatory rheumatism and depression after chikungunya infection?

Authors:  Alfonso J Rodriguez-Morales; Karol Liceth Hoyos-Guapacha; Sara Lucia Vargas-Zapata; Oscar Mauricio Meneses-Quintero; Julio César Gutiérrez-Segura
Journal:  Rheumatol Int       Date:  2017-05-26       Impact factor: 2.631

Review 5.  Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.

Authors:  Carlos Pineda; Roberto Muñoz-Louis; Carlo V Caballero-Uribe; Diego Viasus
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

6.  Mapping Zika virus disease incidence in Valle del Cauca.

Authors:  Alfonso J Rodriguez-Morales; Maria Leonor Galindo-Marquez; Carlos Julian García-Loaiza; Juan Alejandro Sabogal-Roman; Santiago Marin-Loaiza; Andrés F Ayala; Guillermo J Lagos-Grisales; Carlos O Lozada-Riascos; Esteban Parra-Valencia; Jorge H Rojas-Palacios; Eduardo López; Pío López; Martin P Grobusch
Journal:  Infection       Date:  2016-10-14       Impact factor: 3.553

7.  Impaired quality of life after chikungunya virus infection: a 12-month follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia.

Authors:  Alfonso J Rodriguez-Morales; Victor Manuel Restrepo-Posada; Nathalia Acevedo-Escalante; Esteban David Rodríguez-Muñoz; Manuela Valencia-Marín; Juan D Castrillón-Spitia; José J Londoño; Hector D Bedoya-Rendón; Javier de Jesús Cárdenas-Pérez; Jaime A Cardona-Ospina; Guillermo J Lagos-Grisales
Journal:  Rheumatol Int       Date:  2017-08-21       Impact factor: 2.631

8.  Fatal Sickle Cell Disease and Zika Virus Infection in Girl from Colombia.

Authors:  Laura Arzuza-Ortega; Arnulfo Polo; Giamina Pérez-Tatis; Humberto López-García; Edgar Parra; Lissethe C Pardo-Herrera; Angélica M Rico-Turca; Wilmer Villamil-Gómez; Alfonso J Rodríguez-Morales
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

9.  Mapping Zika virus infection using geographical information systems in Tolima, Colombia, 2015-2016.

Authors:  Alfonso J Rodriguez-Morales; Maria Leonor Galindo-Marquez; Carlos Julian García-Loaiza; Juan Alejandro Sabogal-Roman; Santiago Marin-Loaiza; Andrés Felipe Ayala; Carlos O Lozada-Riascos; Andrea Sarmiento-Ospina; Heriberto Vásquez-Serna; Carlos E Jimenez-Canizales; Juan Pablo Escalera-Antezana
Journal:  F1000Res       Date:  2016-04-05

10.  ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics.

Authors:  Alberto E Paniz-Mondolfi; Alfonso J Rodriguez-Morales; Gabriela Blohm; Marilianna Marquez; Wilmer E Villamil-Gomez
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-07-22       Impact factor: 3.944
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.